Trials / Recruiting
RecruitingNCT06834542
Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors
Single Arm Clinical Study of Autologous Tumor Infiltrating Lymphocyte Injection (GT201) in the Treatment of Advanced Gynecological Tumors
- Status
- Recruiting
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 26 (estimated)
- Sponsor
- Grit Biotechnology · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This study is an early exploration clinical study with one arm. The study consists of two stages, namely the dose escalation stage and the dose extension stage:
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Autologous tumor infiltrating lymphocyte injection（GT201） | GT201 treatment for advanced gynecological tumors (advanced cervical cancer) |
Timeline
- Start date
- 2022-11-01
- Primary completion
- 2026-10-31
- Completion
- 2026-10-31
- First posted
- 2025-02-19
- Last updated
- 2025-02-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06834542. Inclusion in this directory is not an endorsement.